162 related articles for article (PubMed ID: 26634247)
1. Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.
Seidensaal K; Nollert A; Feige AH; Muller M; Fleming T; Gunkel N; Zaoui K; Grabe N; Weichert W; Weber KJ; Plinkert P; Simon C; Hess J
Mol Cancer; 2015 Dec; 14():204. PubMed ID: 26634247
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
3. Glyoxalase 1 expression is associated with an unfavorable prognosis of oropharyngeal squamous cell carcinoma.
Kreycy N; Gotzian C; Fleming T; Flechtenmacher C; Grabe N; Plinkert P; Hess J; Zaoui K
BMC Cancer; 2017 May; 17(1):382. PubMed ID: 28549423
[TBL] [Abstract][Full Text] [Related]
4. Modulation by retinoic acid (RA) of squamous cell differentiation, cellular RA-binding proteins, and nuclear RA receptors in human head and neck squamous cell carcinoma cell lines.
Zou CP; Clifford JL; Xu XC; Sacks PG; Chambon P; Hong WK; Lotan R
Cancer Res; 1994 Oct; 54(20):5479-87. PubMed ID: 7522960
[TBL] [Abstract][Full Text] [Related]
5. The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer.
Kim H; Lapointe J; Kaygusuz G; Ong DE; Li C; van de Rijn M; Brooks JD; Pollack JR
Cancer Res; 2005 Sep; 65(18):8118-24. PubMed ID: 16166285
[TBL] [Abstract][Full Text] [Related]
6. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
[TBL] [Abstract][Full Text] [Related]
7. MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer.
Shiah SG; Hsiao JR; Chang HJ; Hsu YM; Wu GH; Peng HY; Chou ST; Kuo CC; Chang JY
J Biomed Sci; 2020 Apr; 27(1):46. PubMed ID: 32238162
[TBL] [Abstract][Full Text] [Related]
8. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
9. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
[TBL] [Abstract][Full Text] [Related]
10. CRABP1 and CRABP2 Protein Levels Correlate with Each Other but Do Not Correlate with Sensitivity of Breast Cancer Cells to Retinoic Acid.
Enikeev AD; Komelkov AV; Axelrod ME; Galetsky SA; Kuzmichev SA; Tchevkina EM
Biochemistry (Mosc); 2021 Feb; 86(2):217-229. PubMed ID: 33832420
[TBL] [Abstract][Full Text] [Related]
11. Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.
Flahaut M; Jauquier N; Chevalier N; Nardou K; Balmas Bourloud K; Joseph JM; Barras D; Widmann C; Gross N; Renella R; Mühlethaler-Mottet A
BMC Cancer; 2016 Oct; 16(1):781. PubMed ID: 27724856
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid 4-hydroxylase-mediated catabolism of all-trans retinoic acid and the cell proliferation in head and neck squamous cell carcinoma.
Kim SY; Yoo SJ; Kwon HJ; Kim SH; Byun Y; Lee KS
Metabolism; 2002 Apr; 51(4):477-81. PubMed ID: 11912557
[TBL] [Abstract][Full Text] [Related]
13. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
[TBL] [Abstract][Full Text] [Related]
14. PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.
Velmurugan BK; Lee CH; Chiang SL; Hua CH; Chen MC; Lin SH; Yeh KT; Ko YC
J Cell Physiol; 2018 Feb; 233(2):1300-1311. PubMed ID: 28516459
[TBL] [Abstract][Full Text] [Related]
15. Retinoids and their receptors in modulation of differentiation, development, and prevention of head and neck cancers.
Lotan R
Anticancer Res; 1996; 16(4C):2415-9. PubMed ID: 8816844
[TBL] [Abstract][Full Text] [Related]
16. Model examination of chemoprevention with retinoids in squamous cell carcinomas of the head and neck region and suitable biomarkers for chemoprevention.
Fabricius EM; Kruse-Boitschenko U; Schneeweiss U; Wildner GP; Hoffmeister B; Raguse JD
Int J Oncol; 2011 Nov; 39(5):1083-97. PubMed ID: 21785820
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of NADPH quinine oxidoreductase 1 overexpression in head and neck squamous cell carcinoma].
Yang Y; Jin T; Liu S; Chen L; Lin L; Han H; Li L; Lin Z
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):463-7. PubMed ID: 25327796
[TBL] [Abstract][Full Text] [Related]
18. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells.
Zou CP; Hong WK; Lotan R
Differentiation; 1999 Jan; 64(2):123-32. PubMed ID: 10234809
[TBL] [Abstract][Full Text] [Related]
19. Suppression of squamous cell carcinoma growth and differentiation by retinoids.
Lotan R
Cancer Res; 1994 Apr; 54(7 Suppl):1987s-1990s. PubMed ID: 8137325
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of retinoic acid sensitivity in pancreatic cancer.
Gupta S; Pramanik D; Mukherjee R; Campbell NR; Elumalai S; de Wilde RF; Hong SM; Goggins MG; De Jesus-Acosta A; Laheru D; Maitra A
Clin Cancer Res; 2012 Jan; 18(1):280-9. PubMed ID: 22010213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
